, Author at ixlayer

News

Pharmaceutical Executive Highlights ixlayer Survey Findings on the Rise of Direct-to-Patient Programs

Pharmaceutical Executive Highlights ixlayer Survey Findings on the Rise of Direct-to-Patient Programs Pharmaceutical Executive recently featured ixlayer’s latest survey of

Services

MM+M Highlights What’s Next for Pharma—And Where ixlayer Fits

Pharmaceutical Executive Highlights ixlayer Survey Findings on the Rise of Direct-to-Patient Programs

Solli Covers ixInsights 2025: What Patients Really Expect and How Pharma Can Deliver

MediaPost Reports on ixInsights 2025 Study That Finds Patients Want Pharma More Involved in Digital Health

HealthPopuli Highlights ixlayer and Ipsos Findings on What Patients Expect from Pharma

Fierce Pharma Highlights How Direct-to-Patient Programs Are Becoming Standard Practice

Pharma’s Next Move: What 2025 Survey Data Reveals About the Future of Direct-to-Patient Programs

Recap: Peer-to-Peer Lunch at Fierce Pharma Week – Building Direct-to-Patient Programs That Work

New ixlayer Survey Finds 73% of Pharma Leaders Are Running or Planning to Launch a DTP Program in the Next Year, and Half Say DTP Will Be Standard Practice Within Five Years